Complete 6,8-dibromo-3-fluoroimidazo[1,2-a]pyrazine Best Choice [WxLEU68Q]
Introducing 6,8-Dibromo-3-Fluoroimidazo[1,2-a]pyrazineWelcome to our inventory, where we offer a high-quality chemical compound, Complete 6,8-dibromo-3-fluoroimidazo[1,2-a]pyrazine Best Choice [WxLEU68Q]. This compound, with the CAS RN 2855165-61-4 and the SMILES code C1=C(N2C=C(N=
Secure Shopping
100% Safe Guarantee
Free Shipping
On orders over $30
Money-Back
30-Day Guarantee
Introducing 6,8-Dibromo-3-Fluoroimidazo[1,2-a]pyrazine
Welcome to our inventory, where we offer a high-quality chemical compound, Complete 6,8-dibromo-3-fluoroimidazo[1,2-a]pyrazine Best Choice [WxLEU68Q]. This compound, with the CAS RN 2855165-61-4 and the SMILES code C1=C(N2C=C(N=C(C2=N1)Br)Br)F, is a versatile and valuable addition to your research and development projects. Its chemical formula, C6H2Br2FN3, and molecular weight of 294.91 g/mol, make it a potent candidate for various applications in the chemical industry.
Key Features and Specifications
Our 6,8-Dibromo-3-Fluoroimidazo[1,2-a]pyrazine is known for its purity and stability, making it a reliable choice for your experiments. Here are some of the key features and specifications:- Storage: This compound should be stored in an inert atmosphere at room temperature to maintain its integrity.
- Cat. No.: BDJHH044594, ensuring easy identification and tracking in your inventory.
Practical Applications and Benefits
6,8-Dibromo-3-Fluoroimidazo[1,2-a]pyrazine has a wide range of applications in organic synthesis and medicinal chemistry. Its unique chemical structure and properties make it ideal for:- Medicinal Chemistry: The compound can be used in the development of novel pharmaceuticals and drug candidates.
- Organic Synthesis: It serves as a building block for synthesizing more complex molecules.
What Our Customers Say
Absolutely no complaints!
It's a wonderful little tool.
- Celeste D..
Absolutely no complaints!
I'm very happy with my item.
- Kari V..
Absolutely no complaints!
So pleased I made this purchase.
- Evan O..